107 related articles for article (PubMed ID: 22102479)
1. Evaluation of EGFR mutation status in cytology specimens: an institutional experience.
Aisner DL; Deshpande C; Baloch Z; Watt CD; Litzky LA; Malhotra B; Sepulveda AR; Langer C; Evans T; Van Deerlin VM
Diagn Cytopathol; 2013 Apr; 41(4):316-23. PubMed ID: 22102479
[TBL] [Abstract][Full Text] [Related]
2. EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC).
Reynolds JP; Tubbs RR; Minca EC; MacNamara S; Almeida FA; Ma PC; Pennell NA; Cicenia JC
Lung Cancer; 2014 Nov; 86(2):158-63. PubMed ID: 25263855
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of 2-year experience with EGFR mutation analysis of small diagnostic samples.
Hlinkova K; Babal P; Berzinec P; Majer I; Mikle-Barathova Z; Piackova B; Ilencikova D
Diagn Mol Pathol; 2013 Jun; 22(2):70-5. PubMed ID: 23628817
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas.
Khode R; Larsen DA; Culbreath BC; Parrish S; Walker KL; Sayage-Rabie L; Beissner RS; Rao A
Cancer Cytopathol; 2013 Jul; 121(7):361-9. PubMed ID: 23364874
[TBL] [Abstract][Full Text] [Related]
5. Detection of epidermal growth factor receptor mutation in non-small-cell lung carcinoma using cytological and histological specimens.
Xu H; Sun W; Zhang G; Cheng Y
J BUON; 2015; 20(1):142-5. PubMed ID: 25778309
[TBL] [Abstract][Full Text] [Related]
6. Strategic management of transthoracic needle aspirates for histological subtyping and EGFR testing in patients with peripheral lung cancer: An institutional experience.
Son C; Kang EJ; Roh MS
Diagn Cytopathol; 2015 Jul; 43(7):532-8. PubMed ID: 25427228
[TBL] [Abstract][Full Text] [Related]
7. Detection of epidermal growth factor receptor gene mutations in cytology specimens from patients with non-small cell lung cancer utilising high-resolution melting amplicon analysis.
Smith GD; Chadwick BE; Willmore-Payne C; Bentz JS
J Clin Pathol; 2008 Apr; 61(4):487-93. PubMed ID: 17908804
[TBL] [Abstract][Full Text] [Related]
8. High concordance of EGFR mutation status between histologic and corresponding cytologic specimens of lung adenocarcinomas.
Sun PL; Jin Y; Kim H; Lee CT; Jheon S; Chung JH
Cancer Cytopathol; 2013 Jun; 121(6):311-9. PubMed ID: 23225576
[TBL] [Abstract][Full Text] [Related]
9. Suitability of computed tomography-guided biopsy specimens for subtyping and genotyping of non-small-cell lung cancer.
Hsiao SH; Chung CL; Lee CM; Chen WY; Chou YT; Wu ZH; Chen YC; Lin SE
Clin Lung Cancer; 2013 Nov; 14(6):719-25. PubMed ID: 23891241
[TBL] [Abstract][Full Text] [Related]
10. Comparison study of the performance of the QIAGEN EGFR RGQ and EGFR pyro assays for mutation analysis in non-small cell lung cancer.
Cushman-Vokoun AM; Crowley AM; Rapp SA; Greiner TC
Am J Clin Pathol; 2013 Jul; 140(1):7-19. PubMed ID: 23765529
[TBL] [Abstract][Full Text] [Related]
11. Cytomorphological correlates of epidermal growth factor receptor mutations in lung carcinoma.
Brachtel EF; Iafrate AJ; Mark EJ; Deshpande V
Diagn Cytopathol; 2007 May; 35(5):257-62. PubMed ID: 17427221
[TBL] [Abstract][Full Text] [Related]
12. EGFR mutation testing using archival-stained smears in non-small cell lung carcinoma.
Ozluk Y; Firat P; Yegen G; Hocaoglu J; Tas S; Yilmazbayhan D
Cytopathology; 2017 Feb; 28(1):35-45. PubMed ID: 27389045
[TBL] [Abstract][Full Text] [Related]
13. Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer.
Kimura H; Kasahara K; Kawaishi M; Kunitoh H; Tamura T; Holloway B; Nishio K
Clin Cancer Res; 2006 Jul; 12(13):3915-21. PubMed ID: 16818687
[TBL] [Abstract][Full Text] [Related]
14. The peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations in bronchoscopic cytological specimens of non-small cell lung cancer.
Yamada N; Oizumi S; Asahina H; Shinagawa N; Kikuchi E; Kikuchi J; Sakakibara-Konishi J; Tanaka T; Kobayashi K; Hagiwara K; Nishimura M
Oncology; 2012; 82(6):341-6. PubMed ID: 22677909
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer.
Fukui T; Ohe Y; Tsuta K; Furuta K; Sakamoto H; Takano T; Nokihara H; Yamamoto N; Sekine I; Kunitoh H; Asamura H; Tsuchida T; Kaneko M; Kusumoto M; Yamamoto S; Yoshida T; Tamura T
Clin Cancer Res; 2008 Aug; 14(15):4751-7. PubMed ID: 18676744
[TBL] [Abstract][Full Text] [Related]
16. Comparison of epidermal growth factor receptor mutation statuses in tissue and plasma in stage I-IV non-small cell lung cancer patients.
Zhao X; Han RB; Zhao J; Wang J; Yang F; Zhong W; Zhang L; Li LY; Wang MZ
Respiration; 2013; 85(2):119-25. PubMed ID: 22797485
[TBL] [Abstract][Full Text] [Related]
17. EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib.
Kimura H; Fujiwara Y; Sone T; Kunitoh H; Tamura T; Kasahara K; Nishio K
Br J Cancer; 2006 Nov; 95(10):1390-5. PubMed ID: 17060940
[TBL] [Abstract][Full Text] [Related]
18. Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer.
Chou TY; Chiu CH; Li LH; Hsiao CY; Tzen CY; Chang KT; Chen YM; Perng RP; Tsai SF; Tsai CM
Clin Cancer Res; 2005 May; 11(10):3750-7. PubMed ID: 15897572
[TBL] [Abstract][Full Text] [Related]
19. Use of mutation specific antibodies to detect EGFR status in small biopsy and cytology specimens of lung adenocarcinoma.
Hasanovic A; Ang D; Moreira AL; Zakowski MF
Lung Cancer; 2012 Aug; 77(2):299-305. PubMed ID: 22542171
[TBL] [Abstract][Full Text] [Related]
20. Cytology smears as diagnostic material for EGFR gene testing in non-small cell lung cancer.
Powrózek T; Krawczyk P; Pankowski J; Reszka K; Jakubiak M; Obrochta A; Wojas-Krawczyk K; Buczkowski J; Milanowski J
Tumori; 2015 Nov; 101(6):e151-3. PubMed ID: 26108238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]